Faculty Directory
Dr. Jiban Jyoti Panda
Associate Professor (Scientist-E)
Our group's major aim is to develop different nanostructures for treating Brain/CNS-associated disorders like glioblastoma, Alzheimer's, Brain-Stroke etc. Our research work is directed towards the utilization of a variety of biochemical, biophysical, and molecular biology-based methodologies to generate different biomolecular-based (peptide/protein/amino acid) self-assembled nanostructures for potential applications in the field of Neuro-nanomedicine. We are trying to utilize our developed bio-nano materials for different cutting-edge applications majorly to treat neurological disorders such as Alzheimer's disease, glioblastoma, cataract etc. One of the major aims of our research is to enable therapeutic molecules to cross through the Blood-Brain Barrier for the effective therapy of many dreaded and debilitating brain/CNS disorders. We also develop biomolecular-based nanoformulations for anti-Cancer therapy and neural tissue engineering targeted applications. Besides, our group also works towards the development of various nanosensing platforms based on SERS, electrochemical or fluorescence-based techniques for aiding detection and diagnosis of glioblastoma, neurodegenerative disorders etc. Prime research interests: Anti-cancer drug delivery, Neural-drug delivery, Neural-tissue engineering, Biosensing, Peptide and biomolecular self-assembly
Contact Information :
-
Email:
jyoti@inst.ac.in -
Personal Webpage:
Personal Webpage -
Google Link:
Google Link
-
Ours is a Neuro-nanotherapeutics group, where we strive to develop nanomedicine for targeting various neurological disorders like glioblastoma, brain stroke, Alzheimer etc. Our aim is to develop novel systems and methods for achieving effective delivery across the blood brain barrier for treating glioblastomas and other neurodegenerative disorders. Our other important aim is to develop biocompatible drug delivery systems for effective cancer therapy. Developing smart and biocompatible scaffolds for tissue engineering applications is also one of our research aims.
-
Dr Panda and group work towards the development of different nanomedicine based platforms for combating neurological disorders such as delivery across the blood brain barrier; targeted nanomedicine for anti-glioma therapy; stimuli responsive on demand drug delivery platforms; nanomedicine targeting the protein aggregation disorders; theranostic nanostructures as sensing, diagnosis and therapeutic platforms.
Current Group Members
-
ROSHNI RUPASHRI MISHRA
Email: roshni.ph24231@inst.ac.in
Reg. No.: PH24231
-
JYOTI YADAV
Email: jyoti.ph24211@inst.ac.in
Reg. No.: PH24211
-
PANKAJ KHARRA
Email: pankaj.ph23241@inst.ac.in
Reg. No.: PH23241
-
ANKUSH
Email: ankush.ph23221@inst.ac.in
Reg. No.: PH23221
-
KARTHIKEY SHARMA
Email: karthikey.ph23209@inst.ac.in
Reg. No.: PH23209
-
MR. RAVI KUMAR
Email: ravi.ph22224@inst.ac.in
Reg. No.: PH22224
-
MS. SWAPNIL SRIVASTAVA
Email: swapnil.ph22213@inst.ac.in
Reg. No.: PH22213
-
MR. AMAN KUMAR
Email: aman.ph22201@inst.ac.in
Reg. No.: PH22201
-
MR. HIMANSHU SEKHAR PANDA
Email: himanshu.ph21255@inst.ac.in
Reg. No.: PH21255
-
MS. SAMRAGGI CHOUDHURY
Email: samragi.ph20216@inst.ac.in
Reg. No.: PH20216
-
MS. NIDHI AGGARWAL
Email: nidhi.ph20215@inst.ac.in
Reg. No.: PH20215
-
MS. SONIKA CHIBH
Email: sonika.ph16241@inst.ac.in
Reg. No.: Ph16241
-
MS. MANJU SHARMA
Email: manju.ph17206@inst.ac.in
Reg. No.: PH17206
-
KARANVEER SINGH
Email: karanveer.rp972322@inst.ac.in
Reg. No.: RP972322
-
PANKAJ KHARRA
Email: pankaj.rp922323@inst.ac.in
Reg. No.: RP922323
-
MR. RAVI KUMAR
Email: ravi.rp922222@inst.ac.in
Reg. No.: RP922222
-
MS. KRUTHI K RAO
Email: kruthi.rp972221@inst.ac.in
Reg. No.: RP972221
-
HARSHIKA
Email:
Reg. No.: IN-2024/19
-
SRILEKHA MUTHUMULA
Email:
Reg. No.: IN-2024/12
Alumni
-
DR. RAJKUMAR IMOCHA SINGH
Reg. No.: RA-01-202146
Designation: Post Docs/RA
Jul 2022 - May 2024
-
MS. TARU DUBE
Reg. No.: PH15213
Designation: PhD Scholar
Aug 2015 - Dec 2021
-
1.
Bio-piezoelectric phenylalanine-αβ-dehydrophenylalanine nanotubes as potential modalities for combinatorial electrochemotherapy in glioma cells , Sonika Chibh , Nidhi Aggarwal , Zinnia Mallick 2, Dipanjan Sengupta , Parrydeep Kaur Sachdeva , Chandan Bera , Nitin Yadav , Virander Singh Chauhan , Dipankar Mandal , Jiban Jyoti Panda , Biomaterials Science , September 2023 , 10.1039/d2bm01970a -
2.
Exploiting flow manipulation to engineer the electroactive phase for improved piezo response in size tunable PVDF microspheres via microfluidic technology , Alisha Rohal, Romy Garg, Samraggi Choudhury, Mayanglambam Manolata Devi, Jiban Jyoti Panda, Ambrish Pandey, Bhanu Prakash , Chemical Engineering Journal , 2024 , 491 , 151986 -
3.
Nucleic acid nano-carriers for delivery of Antisense and RNAi therapeutics , Himanshu Sekhar Panda, Samraggi Choudhury, Jiban Jyoti Panda , OpenNano , 2024 , 100208 -
4.
Emerging biosensors in Phenylketonuria , Ritika Shyam, Himanshu Sekhar Panda, Jibanananda Mishra, Jiban Jyoti Panda, Avneet Kour , Clinica Chimica Acta , 2024 , 119725 -
5.
Short term biodistribution and in vivo toxicity assessment of intravenously injected pristine graphene oxide nanoflakes in SD rats , Indranil De, Rashmika Singh, Sushil Kumar, Srishti Singh, Manohar Singh, Jiban Jyoti Panda, Kaushik Ghosh, Durga Prasad Mishra, Manish Singh , Toxicology Research , 2024 , 13 , tfae05 -
6.
Neuroglia targeting nano-therapeutic approaches to rescue aging and neurodegenerating brain , Manju Sharma, Nidhi Aggarwal, Jibanananda Mishra, Jiban Jyoti Panda , International Journal of Pharmaceutics , 2024 , 123950 -
7.
Futuristic Alzheimer's therapy acoustic-stimulated piezoelectric nanospheres for amyloid reduction , Manju Sharma, Samraggi Choudhury, Anand Babu, Varun Gupta, Dipanjan Sengupta, Syed Afroz Ali, Mrunali D Dhokne, Ashok Kumar Datusalia, Dipankar Mandal, Jiban Jyoti Panda , Biomaterials Science , 2024 -
8.
Temporal Optimization in the Synthesis of Multifunctional Nano Agents for Enhanced MRI Contrast, Hyperthermia Therapy, and ROS Generation , Pallavi Kadian, Anshika Kesari, Imocha Rajkumar Singh, Samraggi Choudhury, Anup Singh, Jiban Jyoti Panda, Jaspreet Kaur Randhawa , Langmuir , 2024 -
9.
Small Peptide–Based Nanodelivery Systems for Cancer Therapy and Diagnosis , IR Singh, N Aggarwal, S Srivastava, JJ Panda, J Mishra , Journal of Pharmacology and Experimental Therapeutics , 2024 , 30-44 , 30-44 -
10.
Anti amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer’s disease , Avneet Kour, Virendra Tiwari, Nidhi Aggarwal, Himanshu Sekhar Panda, Ashwani Kumar, Siddharth Tiwari, Virander Singh Chauhan, Shubha Shukla, Jiban Jyoti Panda , Nanoscale , 2023 , 10.1039/D3NR01558K -
11.
Peptide-metal nanohybrids (PMN): Promising entities for combating neurological maladies , Avneet Kour, Himanshu Sekhar Panda , Imocha Rajkumar Singh, Ashwani Kumar , Jiban Jyoti Panda , Advances in Colloid and Interface Science , 2023 , 10.1016/j.cis.2023.102954 -
12.
Anti-Glioma Activity Achieved by Dual Blood–Brain Barrier/Glioma Targeting Naive Chimeric Peptides-Based Co-Assembled Nanophototheranostics , DubeTaru, and Jiban Jyoti Panda , Pharmaceutics , 2023 , 10.3390/pharmaceutics15010265 -
13.
Near infrared triggered chemo-PTT-PDT effect mediated by glioma directed twin functional-chimeric peptide-decorated gold nanoroses.[IF-7]: , Dube T, Kompella UB, Panda JJ , (2022) , 228: 112407 , J Photochem Photobiol B , doi.org/10.1016/j.jphotobiol.2022.112407 -
14.
In-vitro toxicity assessment of a textile dye Eriochrome Black T and its nano-photocatalytic degradation through an innovative approach using Mf-NGr-CNTs-SnO2 heterostructures.[7.2]: , De I, Pahuja M, Ud Din Wani HM, Dey A, Dube T, Ghosh R, Kankan N, Mishra J, Panda JJ, Maruyama T, Ghosh K, Singh M , (2022) , 243: 113985 , Ecotoxicol Environ Saf , doi.org/10.1016/j.ecoenv.2022.113985 -
15.
Aptamer-nanoconjugates as emerging theranostic systems in neurodegenerative disorders.[IF-5]: , NidhiAggarwal,SamraggiChoudhury,SonikaChibh,Jiban JyotiPanda , (2022) , 100554: , Colloid and Interface Science Communication , doi.org/10.1016/j.colcom.2021.100554 -
16.
Cysteine-phenylalanine Derived Self-assembled Nanoparticles as Glutathione Responsive Drug Delivery Systems in Yeast [ IF-7.6]: , Sonika Chibh, Shradha Suyal, Nidhi Aggarwal, Anand Kumar Bachhawat and Jiban Jyoti Panda , (2022) , Accepted: , Journal of Materials Chemistry B , doi.org/10.1039/D2TB01362B -
17.
Self-Fluorescent Lone Tryptophan Nanoparticles as Theranostic Agents Against Alzheimer’s Disease [IF-10.5]: , Sharma M, Tiwari V, Chaturvedi S, Wahajuddin M, Shukla S, Panda JJ , (2022) , 14: 13079-13093 , ACS Applied Materials & Interfaces , doi.org/10.1021/acsami.2c01090 -
18.
Recent advances in the fabrication and bio- medical applications of self-assembled dipeptide nanostructures.[IF-5.3]: , Sonika Chibh,Jibanananda Mishra,Avneet Kour,Virander S Chauhan ,Jiban J Panda , (2022) , 16: 139-163 , Nanomedicine , DOI: 10.2217/nnm-2020-0314 -
19.
Continuous flow fabrication of Fmoc-cysteine based nanobowl infused core–shell like microstructures for pH switchable on- demand anti-cancer drug delivery.: , Sonika Chibh,Vibhav Katoch,Avneet Kour, Amit Singh Yadav,Manish Singh,Gopal C,Bhanu Prakash,Jiban Jyoti Panda , (2022) , Biomaterials Science , doi.org/10.1039/D0BM01386B -
20.
Fluorescent dopamine−tryptophan nanocomposites as dual-imaging and antiaggregation agents: New generation of amyloid theranostics with trimeric effects: , Manju Sharma.,Virendra Tiwari,Shubha Shukla,Jiban Jyoti Panda , (2022) , ACS Applied Materials & Interfaces , doi.org/10.1021/acsami.0c13223?ref=pdf -
21.
Anti-Amyloidogenic and FibrilDisaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model.: , Kour A, Dube T, Kumar A, Panda JJ , (2022) , 33: 397-410 , Bioconjug Chem. , doi.org/10.1021/acs.bioconjchem.2c00007 -
22.
Dimension switchable auto-fluorescent peptide-based 1D and 2D nano-assemblies and their self-influence on intracellular fate and drug delivery†.[IF-8.30]: , Sonika Chibh,Komalpreet Kaur,Ujjal K. Gautam,Jiban Jyoti Panda , (2021) , Nanoscale , doi.org/10.1039/D1NR06768K -
23.
Microflow synthesis and enhanced photocatalytic dye degradation performance of antibacterial Bi2O3 nanoparticles.[IF-2.8]: , Vibhav Katoch,Nipun Sharma,Manju Sharma,Mayank Baghoria, Jiban Jyoti Panda,Manish Singh, Bhanu Prakash , (2021) , Environmental Science and Pollution Research , DOI: 10.1007/s11356-020-11711-1 -
24.
Miniatured Fluidics-Mediated Modular Self-Assembly of Anticancer Drug–Amino Acid Composite Microbowls for Combined Chemo-Photodynamic Therapy in Glioma: , Sonika Chibh, Vibhav Katoch, Manish Singh, Bhanu Prakash*, Jiban Jyoti Panda* , (2021) , ACS Biomaterials Science and Engineering , doi.org/10.1021/acsbiomaterials.1c01023 -
25.
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector: , T Dube, A Ghosh, J Mishra, UB Kompella, JJ Panda , (2021) , 4: 2000172 , Adv Therapeutics , doi.org/10.1002/adtp.202000172 -
26.
Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID- 19.[IF-2]: , Vikram Thakur,Radha Kanta Ratho,Jiban Jyoti Panda , (2021) , 32: 131-136 , Virus Diseases , doi.org/10.1007/s13337-021-00679-2 -
27.
Biofabricated smart-nanosilver: Promising armamentarium for cancer and pathogenic diseases.[IF-5]: , Jibanananda Mishra, Avneet Kour, Durdana Sadaf Amin, Jiban Jyoti Panda , (2021) , 44: 100459 , Colloid and Interface Science Communications , DOI:10.1016/J.COLCOM.2021.100459 -
28.
Recent advances in the fabrication and bio-medical applications of self-assembled dipeptide nanostructures: , Chibh S, Mishra J, Kour A, Chauhan VS, Panda JJ , (2021) , 16: 139-163 , Nanomedicine , 10.1007/s11356-020-11711-1 -
29.
Miniatured Fluidics-Mediated Modular Self-Assembly of Anticancer Drug–Amino Acid Composite Microbowls for Combined Chemo-Photodynamic Therapy in Glioma.[IF-4.80]: , Sonika Chibh, Vibhav Katoch, Manish Singh, Bhanu Prakash, Jiban Jyoti Panda , (2021) , Accepted: , ACS Biomaterials Science and Engineering , doi.org/10.1021/acsbiomaterials.1c01023 -
30.
Flow synthesis and in-channel photocatalysis of antimicrobially active ZnS quantum dots using an efficient planar PMMA microreactor: , Bhanu Prakash, Astha Singh, Vibhav Katoch, Manju Sharma, Jiban Jyoti Panda, Jadab Sharma and Ashok K Ganguli , (2021) , Nano Express , https://doi.org/10.1088/2632-959X/abcadf -
31.
Continuous Flow Fabrication of Fmoc-Cysteine Based Nanobowl Infused Core-Shell Like Microstructures for pH Switchable on Demand Anti-Cancer Drug Delivery: , Sonika Chibh, Vibhav Katoch, Avneet Kour, Farheen Khanam, Amit Yadav, Manish Singh, Gopal C Kundu, Bhanu Prakash, Jiban Jyoti Panda , (2021) , Biomaterials Science -
32.
Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes: , Verma P, Biswas S, Yadav N, Khatri A, Siddiqui H, Panda JJ, Rawat BS, Tailor P, Chauhan VS , (2021) , Molecular Pharmaceutics , 10.1021/acs.molpharmaceut.1c00451 -
33.
Dual Blood-Brain Barrier-Glioma Targeting Peptide-Poly(levodopamine) Hybrid Nanoplatforms as Potential Near Infrared Phototheranostic Agents in Glioblastoma.[IF-4.9]: , Dube T, Kumar N, Bishnoi M, Panda JJ , (2021) , Bioconjugate Chemistry , doi.org/10.1021/acs.bioconjchem.1c00321 -
34.
Engineered Biocompatible and Stable Dipeptide Hydrogel with Tunable Mechanical and Cell Growth Properties to Embolden Neuroglial Cell Growth.[IF-2.5]: , Saurabh Mandal, Taru Dube, Ashish K Mohapatra, Samraggi Choudhury, Farheen Khanam, Pratik Yadav, Virander S Chauhan, Jibanananda Mishra, Jiban J Panda , (2021) , 27: , International Journal of Peptide Research and Therapeutics , doi.org/10.1007/s10989-021-10290-0 -
35.
L-3,4-Dihydroxyphenylalanine templated anisotropic gold nano/micro-roses as potential disrupters/inhibitors of α-crystallin protein and its gleaned model peptide aggregates: , Avneet Kour,Shikha Sharma,Taru Dube , (2020) , International Journal of Biological Macromolecules , 10.1016/j.ijbiomac.2020.09.112 -
36.
Exposure of calcium carbide induces apoptosis in mammalian fibroblast L929 cells.[IF-2.7]: , Indranil De, S Rajesh, Avneet Kour, Henna Wani, Prashant Sharma, Jiban Jyoti Panda, Manish Singh , (2020) , 31: 159-168 , Toxicol Mech Methods , doi.org/10.1080/15376516.2020.1849484 -
37.
l-3, 4-Dihydroxyphenylalanine templated anisotropic gold nano/micro-roses as potential disrupters/inhibitors of α-crystallin protein and its gleaned model peptide aggregates: , Avneet Kour; Shikha Sharma; Taru Dube; Anjali Bisht; Manju Sharma; Jibanananda Mishra; Md Ehesan Ali; Jiban Jyoti Panda , (2020) , 163: 2374-2391 , Intl. J. Biol. Macromol. , 10.1016/j.ijbiomac.2020.09.112 -
38.
Fluorescent Dopamine-Tryptophan Nanocomposites as Dual-Imaging and Antiaggregation Agents: New Generation of Amyloid Theranostics with Trimeric Effects: , Manju Sharma, Virendra Tiwari, Shubha Shukla, Jiban Jyoti Panda , (2020) , 20: 44180-44194 , ACS Appl Mater Interfaces , 10.1021/acsami.0c13223 -
39.
Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections: , Jasjeet Kaur,Avneet Kour , (2020) , AAPS PharmSciTech , 10.1208/s12249-020-01763-4 -
40.
Continuous Flow Reactor for the Controlled Synthesis and Inline Photocatalysis of Antibacterial Ag2 S Nanoparticles: , Prakash B, Katoch V, Shah A, Sharma M, Devi MM, Panda JJ, Sharma J, Ganguli AK , (2020) , Photochem Photobiol. , 10.1111/php.13297
-
1.
Pharmaceutical Applications of Supramolecules , Avneet Kour, Aman Tiwari, Jiban Jyoti Panda* and Jibanananda Mishra , Springer 2021 , 2.Editors, Cancer Nanothernostics -
2.
Progressive Approach of Supramolecules Towards the Advancement of Antimicrobial Drugs , Manju Sharma, Nidhi Aggarwal, Sonika Chibh, Avneet Kour, Samraggi Choudhury & Jiban Jyoti Panda , 2023 , 10.1007/978-3-031-21900-9_5 -
3.
, Samraggi Choudhury, Nidhi Aggarwal, Jiban Jyoti Panda* and Jibanananda Mishra , 2021 , Springer 2021 -
4.
, Samraggi Choudhury, Nidhi Aggarwal, Jiban Jyoti Panda* and Jibanananda Mishra , 2021 , Springer 2021 -
5.
Nanoworld of peptide self-assembly. In: souvenir of silver jubilee celebration of Jupiter Biosciences , Chauhan VS , (2010) , 37-43
-
1.
Enhanced and effective delivery of microrna by using ligand modified self-assembled cationic dipeptide nanoparticles in hepatocellular carcinoma (HCC) : , A Varshney, JJ Panda, AK Singh, SB Rooge, S Biswas, SK Sarin , (2019) , S411: , Journal of Hepatology -
2.
Nanoparticles generated from a tryptophan derivative: physical characterization and anticancer drug delivery: , Taru Dube , (2017) , Crick Nano Science Day,CSIO, Chandigarh -
3.
Development of Biocompatible Peptide Based Nanostructures Capable Of Traversing the Blood Brain Barrier for Targeting Glioblastoma/Brain Tumors: , Crick Nano Science Day,INST , (2016)
- 1. Design Of Low Molecular Weight Dipeptides Containing Conformationally Constraining Residue Dphe Into Stimuli Responsive Self-assembling Hydrogels With Potential Drug Delivery Applications: , 1735/DEL/2008, (2008)
- 2. Modified Dipeptide Nanoparticles: Vehicles For Tumor Targeted Drug And Gene Delivery: , Panda JJ, (2012)
- 3. Chitosan Based Mucoadhesive Nanoparticles Containing Cpl-1 Endolysin For Systemic Treatment Of streptococcus Pneumoniae , Sanjay Chhibber1, Vijay Singh Gondil, Kusum Harjai and Jiban Jyoti Panda
Indian National Young Academy of Sciences (INYAS), Membership
Har Gobind Khorana Young Innovative Biotechnologist Award, 2021
ICMR-DHR International Fellowship for Biomedical Scientists-2019
Best Poster Award, DBT-BIOCARE conclave 2019.
Best poster at Indian International Science Festival (IISF) 2017 held in Chennai during 13-16 October, 2017.
Best Free Paper Presentation Award, ASIA ARVO 2013, New Delhi.
American Association of Pharmaceutical Scientist (AAPS) Graduate Student Symposium Award in Formulation Design and Development, 2011.
Organization of Pharmaceutical Producers of India (OPPI) Young Scientist Award 2011.
The UNESCO-L’OREAL International Fellowship 2011 for Young Women in Life Sciences
Best poster award’ in FCS, 2011, ICGEB, New Delhi, India.
Received ‘Best poster award’ in NCMB 2009, at CCMB, Hyderabad.
Received ‘Budding Nanotechnologist award’ in ‘2nd Winter School of Nanotechnology 2009’, organized at NIPER, Chandigarh.
Awarded CSIR-NET, ICMR and DBT Junior Research Fellowships.
Awarded Certificate of Merit for reasons of outstanding academic performance and being among the top 0.1% of successful candidates of AISSCE 2000 in Biology.
Awarded Certificate of Merit for reasons of outstanding academic performance and being among the top 0.1% of successful candidates of AISSE 1998 in Mathematics.
National Merit Scholarship for outstanding performance in AISSCE 2000 by CBSE.
National Merit Scholarship for outstanding performance in AISSE 1998 by CBSE.
Member of American Association of Pharmaceutical Scientists.
Member of American Chemical Society.
Associate Member of American Association for Cancer Research.
Reviewer for the journal ‘Pharmaceutical Research’.
Reviewer for the Journal of Ocular Pharmacology and Therapeutics.
Reviewer for the journal ‘Therapeutic Delivery’.
● Member of Indian Society for Nanomedicine.
● Reviewer for Milllitary Medical Research, ACS Applied Materials and Interfaces
● Reviewer for the journal ‘Pharmaceutical Research’.
● Reviewer for the journal ‘Therapeutic Delivery’.
● Reviewer for Molecular Therapeutics.
● Reviewer for Journal of Nanobiotechnology
● Reviewer for ACS applied nanomaterials.
● Reviewer for ACS Biomedical Science and Engineering
● Reviewer for Small
Scientist E:Institute of Nano Science and Technology, Phase 10, Sector 64,, Mohali Punjab, India (March 2014 to Present till date )
Visiting Research Scholar:Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver,, USA (April 2013 to March 2014 )
UNESCO-L?Oreal International Fellow:Skagg’s School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver,, USA (December 2011 to December 2013 )
Research Associate:Malaria Research Lab., International Center for Genetic Engineering and Biotechnology (ICGEB), ArunaAsaf Ali Marg, JNU Complex,, New Delhi (December 2010 to December 2011 )
Senior Research Fellow:Malaria Research Lab., ICGEB, ArunaAsaf Ali Marg, JNU Complex, New Delhi (August 2008 to July 2010 )
Junior Research Fellow:Malaria Research Lab., ICGEB, ArunaAsaf Ali Marg, JNU Complex,, New Delhi (August 2006 to July 2008 )
Junior Research Fellow:Laboratory for Nanomedicine, Institute of Life Science, Bhubaneswar,, Orissa, India (December 2005 to May 2006 )
-
Title: Development of Versatile, Multifunctional and Adaptable Peptide Nanofiber Scaffolds with Potential for Promoting Neuritogenesis in Brain Injury
PI: Dr. Jiban Jyoti Panda
Funding Amount: 3500000
Tenure: 5 years
Funding Agency: DST
-
Title: Glioma Targeting Anticancer Peptide Theranostic Nanoparticles
PI: Dr. Manish Singh Role
CO-PI: Dr. Jiban Jyoti Panda
Funding Amount: Rs 52 Lakhs
Tenure: 3 years
Funding Agency: DBT Biocare
-
Title: Multimodal Glioblastoma Therapy by Blood Brain Barrier Traversing and Glioma Targeting Anti-cancer Peptide Theranostic Nanoparticles
PI: Dr. Jiban Jyoti Panda
Funding Amount: 5200000
Tenure: 3 years
Funding Agency: DBT
-
Title: Hierarchically Organized Amino Acid/protein Core-Shell Nanostructures With 2 Photon Responsive off-on Switchable Lids for Light Activable Delivery of an Array of Anti-miRNA Therapeutics in Glioblastoma
PI: Dr. Jiban Jyoti Panda
Funding Amount: 5900000
Tenure: 3 years
Funding Agency: DBT
-
Title: Enhanced osteogenesis promoted by bone injury specific co-delivery of BMP2 and Noggin Si-RNA loaded in microfluidically fabricated amino acid-based nanobowls with pH tunable lids
PI: Dr. Jiban Jyoti Panda
Funding Amount: 4800000
Tenure: 3 year
Funding Agency: DBT
-
Title: Photo-theranostic catecholamine-bdnf-protein hybrid nanocomplexes for multifacetedand effective Alzheimer's therapy
PI: Dr. Jiban Jyoti Panda
Funding Amount: 4000000
Tenure: 3 year
Funding Agency: DST-SERB
-
Title: Blood brain barrier targeting and lysosome directed .. targeting catecholamine polydot based theragnostic nanosystems for enhanced therapy ofAlzheimer's disease as exemplified in a zebra fish model
PI: Dr.Jiban Jyoti Panda
Funding Amount: 1800000
Tenure: 6/7/2023-5/7/2026
Funding Agency: CSIR
-
Title: Development of novel theranostic nanoplatforms for targeted combination therapy for liver cancer
PI: Dr.Jiban Jyoti Panda
Funding Amount: 2500000